ImmuOne raised €2.2M in a funding round in Oct 2023. The company is based in London, UK. Investors in the round: EIS funds, MEIF Proof of Concept & Early Stage Fund, Pioneer Group. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €2.2M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
